BPC-157 + TB-500 10mg — Research Peptide
LAB 101 BPC-157 + TB-500 10mg is a lyophilised research peptide blend containing BPC-157 and TB-500, supplied for controlled laboratory and in-vitro research applications.
BPC-157 is a synthetic peptide commonly investigated in preclinical research involving tissue-repair processes, angiogenic signalling, gastrointestinal biology and inflammatory pathways. TB-500 is a synthetic peptide associated with thymosin beta-4 research and is studied in experimental models involving cell migration, cytoskeletal organisation, tissue remodelling and repair-related processes.
The combination is of research interest where investigators are examining the two peptides within the same experimental framework, including studies relating to cellular repair and tissue-remodelling pathways. Evidence for these compounds remains predominantly preclinical, and research findings should not be interpreted as established therapeutic effects in humans.
For researchers looking for BPC-157 + TB-500 in Australia, LAB 101 BPC-157 + TB-500 10mg is supplied in lyophilised form with a focus on product transparency, consistency and accessible batch documentation. All our peptides are independently verified at ≥99% purity.
Product: BPC-157 + TB-500
Quantity: 10mg total
Form: Lyophilised powder
Research areas: Tissue-repair pathways, cell migration, angiogenic signalling, tissue remodelling and cellular recovery research
Purity: >99%
Location: Australia
Research Use Only: This product is supplied strictly for laboratory and scientific research purposes. It is not intended for human consumption, therapeutic use, injection or self-administration.
For laboratory and in-vitro research purposes only. Not intended for human or animal consumption, administration, diagnostic, therapeutic or veterinary use.
